Does use of biosimilar G-CSF change plerixafor utilization during stem cell mobilization for autologous stem cell transplant?

被引：0
|
作者：
Abdallah, Nadine [1 ]
Kim, Seongho [2 ]
Ayash, Lois [2 ]
Klimecki, Scott [3 ]
Ventimiglia, Marie [3 ]
Alavi, Asif [2 ]
Ratanatharathorn, Voravit [2 ]
Uberti, Joseph [2 ]
Deol, Abhinav [2 ]
机构：
[1] Wayne State Univ, Detroit Med Ctr, Dept Med, Detroit, MI USA
[2] Wayne State Univ, Karmanos Canc Inst, Dept Oncol, Detroit, MI 48202 USA
[3] Karmanos Canc Inst, Detroit, MI USA
来源：
BONE MARROW TRANSPLANTATION | 2020年 / 55卷 / 08期
关键词：
ALGORITHM;
D O I：
10.1038/s41409-019-0744-5
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：1655 / 1657
页数：3
相关论文
共 50 条
  • [41] MOBILIZATION WITH CHEMOTHERAPY COMPARED TO G-CSF ALONE: AN ANALYSIS OF RESOURCE USE AND COST IN AUTOLOGOUS STEM CELL TRANSPLANT PATIENTS
    Dembek, C.
    Pelletier, E. M.
    Smith, P. J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 692 - 693
  • [42] MOBILIZATION WITH CHEMOTHERAPY COMPARED TO G-CSF ALONE: AN ANALYSIS OF RESOURCE USE AND COST IN AUTOLOGOUS STEM CELL TRANSPLANT PATIENTS
    Pelletier, E. M.
    Smith, P. J.
    Dembek, C. J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (02) : 38 - 38
  • [43] What is the role of biosimilar G-CSF agents in hematopoietic stem cell mobilization at present?
    Korkmaz, Serdal
    Altuntas, Fevzi
    TRANSFUSION AND APHERESIS SCIENCE, 2017, 56 (06) : 795 - 799
  • [44] Mobilization of autologous and allogeneic peripheral blood stem cells for stem cell transplantation using biosimilar G-CSF - An Up-date
    Michael, S.
    Publicover, A.
    Danylesko, I.
    Lorenz, K.
    Orchard, K. H.
    Schmitt, A.
    Nagler, A.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S334 - S334
  • [45] G-CSF Only Versus Chemotherapy and G-CSF Peripheral Blood Stem Cell Mobilization for Autologous Hematopoietic Stem Cell Transplant-Assessing a Change in Regime due to the COVID-19 Pandemic
    Wolf, Julia S.
    Seymour, Frances
    Parrish, Christopher
    Chandler, Thea
    Holt, Matthew
    Griffin, James
    Karakantza, Marina
    JOURNAL OF CLINICAL APHERESIS, 2025, 40 (02)
  • [46] Outcomes and costs of autologous stem cell mobilization with chemotherapy plus G-CSF vs G-CSF alone
    Sung, A. D.
    Grima, D. T.
    Bernard, L. M.
    Brown, S.
    Carrum, G.
    Holmberg, L.
    Horwitz, M. E.
    Liesveld, J. L.
    Kanda, J.
    McClune, B.
    Shaughnessy, P.
    Tricot, G. J.
    Chao, N. J.
    BONE MARROW TRANSPLANTATION, 2013, 48 (11) : 1444 - 1449
  • [47] Outcomes and costs of autologous stem cell mobilization with chemotherapy plus G-CSF vs G-CSF alone
    A D Sung
    D T Grima
    L M Bernard
    S Brown
    G Carrum
    L Holmberg
    M E Horwitz
    J L Liesveld
    J Kanda
    B McClune
    P Shaughnessy
    G J Tricot
    N J Chao
    Bone Marrow Transplantation, 2013, 48 : 1444 - 1449
  • [48] CYCLOPHOSPHAMIDE OR PLERIXAFOR AND G-CSF STEM CELL MOBILIZATION (SCM): INITIAL COST COMPARISON ANALYSIS
    Jagasia, M. H.
    Pickard, S.
    Chen, H.
    Dixon, S.
    Savani, B. N.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S202 - S203
  • [49] Spontaneous splenic rupture following stem cell mobilization with G-CSF and plerixafor in AL amyloidosis
    Lessi, Federica
    Marson, Piero
    Colpo, Anna
    Marino, Filippo
    Branca, Antonio
    Tison, Tiziana
    Adami, Fausto
    TRANSFUSION AND APHERESIS SCIENCE, 2016, 54 (02) : 256 - 258
  • [50] Clinical outcomes of multiple myeloma patients who undergo autologous hematopoietic stem cell transplant with G-CSF or G-CSF and plerixafor mobilized grafts
    Shah, Harsh
    Kim, Seongho
    Singh, Paramveer
    Alavi, Asif
    Ratanatharathorn, Voravit
    Ayash, Lois
    Uberti, Joseph
    Deol, Abhinav
    AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (02) : 198 - 204
12345